4-bromohomoibotenic-acid and 2-3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

4-bromohomoibotenic-acid has been researched along with 2-3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline* in 1 studies

Other Studies

1 other study(ies) available for 4-bromohomoibotenic-acid and 2-3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline

ArticleYear
Effects of bromohomoibotenate on metabotropic glutamate receptors.
    Neuroreport, 1994, Dec-20, Volume: 5, Issue:18

    (S)-Bromohomoibotenic acid [(S)-BrHIbo] stereoselectively antagonized glutamate-stimulated phosphoinositide (PI) hydrolysis in baby hamster kidney (BHK) cells expressing mGluR1a in a competitive manner with an IC50 of 250 microM. However, (S)-BrHIbo did not inhibit (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid [(1S,3R)-ACPD]-induced PI hydrolysis in rat hippocampal slices (S)- or (R)-BrHIbo did not show any effects on forskolin-stimulated cAMP-formation in BHK cells expressing mGluR2 or mGluR4 but did displace [3H]2-amino-4-phosphonobutyrate ([3H]AP4) binding from rat corticalmembranes with high affinities (IC50 = 1.0 microM and 1.1 microM, respectively). These data suggest that (S)-BrHIbo may interest with multiple PI-coupled glutamate receptors, however, at concentrations that are several fold higher than for displacement of [3H]AP4 binding from rat cortical membranes.

    Topics: Aminobutyrates; Animals; Binding, Competitive; Cell Line; Cerebral Cortex; Cricetinae; Cyclic AMP; Cycloleucine; Dose-Response Relationship, Drug; Glutamic Acid; Hippocampus; Hydrolysis; Ibotenic Acid; Kidney; Membranes; Phosphatidylinositols; Quinoxalines; Receptors, AMPA; Receptors, Metabotropic Glutamate; Stereoisomerism

1994